|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 7068 Solomon Seal Court |
Address2 | |
City | Springfield |
State | VA |
Zip Code | 22152 |
Country | USA |
3. Principal place of business (if different than line 2)
City | |
State | |
Zip Code | |
Country | |
|
5. Senate ID# 400410940-12
|
||||||||
|
6. House ID# 405940000
|
TYPE OF REPORT | 8. Year | 2009 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date | |
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Andrew Cochran |
Date | 1/19/2010 |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
HR 1346/S 540, the Medical Device Safety Act, to amend the Food Drug and Cosmetic Act to clarify the scope of federal preemption of state law with respect to certain medical devices.
17. House(s) of Congress and Federal agencies Check if None
House of Representatives, Senate
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Andrew |
Cochran |
|
Sr. Counsel, House Financial Services Committee |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CSP
16. Specific lobbying issues
H.R. 1237/ S. 512 (Fairness in Nursing Home Arbitration Act); relating to the use of arbitration agreements to resolve disputes involving nursing home care and nursing home contracts.
H.R. 3226 (Department of Defense Appropriations Act); specific interest in Franken amendment #2588, agreed to; to bar funds in the bill from being used for federal contractors that require employees to sign contracts forcing them to use mandatory binding arbitration to resolve claims under Title VII of the Civil Rights Act of 1964 or any tort related to sexual assault or harassment.
S. 1606 (Foreign Manufacturers Legal Accountability Act); to require foreign manufacturers of
products imported into the United States to establish registered agents in the United States who
are authorized to accept service of process against such manufacturers, and for other purposes.
H.R. 1020/ S.931 (Arbitration Fairness Act); to prohibit mandatory binding arbitration in consumer contracts.
17. House(s) of Congress and Federal agencies Check if None
House of Representatives, Senate
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Andrew |
Cochran |
|
Sr. Counsel, House Financial Services Committee |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code GOV
16. Specific lobbying issues
S. 1504 (Notice Pleading Restoration Act); to provide that Federal courts shall not dismiss complaints under rule 12(b)(6) or (e) of the Federal Rules of Civil Procedure, except under the standards set forth by the Supreme Court of the United States in Conley v. Gibson, 355 U.S. 41 (1957).
H.R. 4115 (Open Access to Courts Act); to provide a restoration of notice pleading in Federal courts.
17. House(s) of Congress and Federal agencies Check if None
House of Representatives, Senate
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Andrew |
Cochran |
|
Sr. Counsel, House Financial Services Committee |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TOR
16. Specific lobbying issues
Lobbying with regard to medical malpractice liability as it relates to any health care reform proposal generally.
H.R. 3962 (Affordable Health Care for America Act); specific interest in minority motion to recommit, not agreed to; to cap noneconomic damages, eliminate joint and several liability, and limit attorney contingency fees.
H.R.3950 (Patient Protection and Affordable Care Act); specific interest in provisions relating to state-based demonstration projects relating to medical liability; and specific interest in proposed amendments relating to medical liability tort reform; including; Ensign amendment #2927 (offered and tabled by vote), and amendments that were filed but not offered:
Corker amendment #3199;
Ensign amendment #3035;
Ensign amendment #3036;
Ensign amendment #3152;
Graham/Chambliss amendment #2829;
Grassley amendment #3182
Grassley amendment #3244
Grassley amendment #3245;
Grassley amendment #3247;
Hutchinson amendment #3141;
Hutchinson amendment #3210;
Kyl amendment #3097;
McConnell amendment #3145;
Murkowski amendment #3255; and
Snowe amendment #2948.
H.R.1478/ S. 1347 (Carmelo Rodriguez Military Medical Accountability Act of 2009); to allow members of the Armed Forces to sue the United States for damages for certain injuries caused by improper medical care.
17. House(s) of Congress and Federal agencies Check if None
House of Representatives, Senate
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Andrew |
Cochran |
|
Sr. Counsel, House Financial Services Committee |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address | |
||||||
City | |
State | |
Zip Code | |
Country | |
21. Client new principal place of business (if different than line 20)
City | |
State | |
Zip Code | |
Country | |
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |